The following is a summary of “Physiological comparison of noninvasive ventilation and high-flow nasal oxygen on inspiratory ...

Rationale Chronic obstructive pulmonary disease (COPD) is the most common indication for domiciliary non-invasive ventilation ...

Non-invasive Ventilation (NIV): Gaining popularity for treating COPD, sleep apnea, and mild to moderate respiratory distress without the need for intubation. NIV is preferred for home-based therapy, ...

InflaRx ends its Phase 3 trial of vilobelimab in pyoderma gangrenosum and shifts focus to INF904 amid efforts to extend its ...

The man kept getting worse; in fact, he seemed to deteriorate before their eyes. Initially, he received supplemental oxygen ...

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.

In the EU, GOHIBIC (vilobelimab) has been granted marketing authorization under exceptional circumstances for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress ...

Background Limited evidence exists on the comparative effectiveness of noninvasive ventilation (NIV) vs invasive mechanical ventilation (IMV) in acute exacerbation of chronic obstructive pulmonary ...

Repeated perinatal antibiotic exposure in very low-birth-weight preterm infants was associated with impaired lung function ...

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to ...

Scientists have identified the first U.S. case of the invasive longhorned tick carrying a bacteria that causes Ehrlichiosis.